Terms: = Ovarian cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Diagnosis
25 results:
1. ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases.
Shao Y; Liu Q; Shi H; Lu B
Diagn Pathol; 2020 Apr; 15(1):35. PubMed ID: 32290854
[TBL] [Abstract] [Full Text] [Related]
2. Low-grade epithelial ovarian cancer: a number of distinct clinical entities?
Oswald AJ; Gourley C
Curr Opin Oncol; 2015 Sep; 27(5):412-9. PubMed ID: 26241347
[TBL] [Abstract] [Full Text] [Related]
3. ovarian mucinous tumor with malignant mural nodules: dedifferentiation or collision?
Desouki MM; Khabele D; Crispens MA; Fadare O
Int J Gynecol Pathol; 2015 Jan; 34(1):19-24. PubMed ID: 25473748
[TBL] [Abstract] [Full Text] [Related]
4. Trismus and diffuse polymyalgia: an unusual presentation of recurrent metastatic ovarian cancer.
Benjamin R; Zhai J; Morgan R; Prakash N
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24835804
[TBL] [Abstract] [Full Text] [Related]
5. Genome-wide single nucleotide polymorphism arrays as a diagnostic tool in patients with synchronous endometrial and ovarian cancer.
Ikeda Y; Oda K; Nakagawa S; Murayama-Hosokawa S; Yamamoto S; Ishikawa S; Wang L; Takazawa Y; Maeda D; Wada-Hiraike O; Kawana K; Fukayama M; Aburatani H; Yano T; Kozuma S; Taketani Y
Int J Gynecol Cancer; 2012 Jun; 22(5):725-31. PubMed ID: 22635024
[TBL] [Abstract] [Full Text] [Related]
6. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract] [Full Text] [Related]
7. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract] [Full Text] [Related]
8. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.
Lalwani N; Prasad SR; Vikram R; Shanbhogue AK; Huettner PC; Fasih N
Radiographics; 2011; 31(3):625-46. PubMed ID: 21571648
[TBL] [Abstract] [Full Text] [Related]
9. Endometrioid carcinoma of the endometrium: pathologic and molecular features.
Azueta A; Gatius S; Matias-Guiu X
Semin Diagn Pathol; 2010 Nov; 27(4):226-40. PubMed ID: 21309258
[TBL] [Abstract] [Full Text] [Related]
10. A 14-year-old female patient with FIGO stage IB endometrial carcinoma: a case report.
Mitamura T; Watari H; Todo Y; Koshida T; Sakuragi N
Int J Gynecol Cancer; 2009 Jul; 19(5):896-7. PubMed ID: 19574781
[TBL] [Abstract] [Full Text] [Related]
11. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract] [Full Text] [Related]
12. Coordinately up-regulated genes in ovarian cancer.
Hough CD; Cho KR; Zonderman AB; Schwartz DR; Morin PJ
Cancer Res; 2001 May; 61(10):3869-76. PubMed ID: 11358798
[TBL] [Abstract] [Full Text] [Related]
13. The hras1 minisatellite locus and risk of ovarian cancer.
Weitzel JN; Ding S; Larson GP; Nelson RA; Goodman A; Grendys EC; Ball HG; Krontiris TG
Cancer Res; 2000 Jan; 60(2):259-61. PubMed ID: 10667571
[TBL] [Abstract] [Full Text] [Related]
14. Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids.
Dokianakis DN; Varras MN; Papaefthimiou M; Apostolopoulou J; Simiakaki H; Diakomanolis E; Spandidos DA
Clin Exp Metastasis; 1999 Jun; 17(4):293-7. PubMed ID: 10545015
[TBL] [Abstract] [Full Text] [Related]
15. Role of tumour markers, cytogenetics.
Lamerz R
Ann Oncol; 1999; 10 Suppl 4():145-9. PubMed ID: 10436809
[TBL] [Abstract] [Full Text] [Related]
16. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases.
Thompson LD; Becker RC; Przygodzki RM; Adair CF; Heffess CS
Am J Surg Pathol; 1999 Jan; 23(1):1-16. PubMed ID: 9888699
[TBL] [Abstract] [Full Text] [Related]
17. Genetics of breast cancer.
Greene MH
Mayo Clin Proc; 1997 Jan; 72(1):54-65. PubMed ID: 9005288
[TBL] [Abstract] [Full Text] [Related]
18. Pancreatic adenocarcinoma: epidemiology and genetics.
Flanders TY; Foulkes WD
J Med Genet; 1996 Nov; 33(11):889-98. PubMed ID: 8950667
[TBL] [Abstract] [Full Text] [Related]
19. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer.
Fujita M; Enomoto T; Wada H; Inoue M; Okudaira Y; Shroyer KR
Am J Clin Pathol; 1996 Mar; 105(3):350-9. PubMed ID: 8602617
[TBL] [Abstract] [Full Text] [Related]
20. The molecular basis of ovarian cancer.
Gallion HH; Pieretti M; DePriest PD; van Nagell JR
Cancer; 1995 Nov; 76(10 Suppl):1992-7. PubMed ID: 8634990
[TBL] [Abstract] [Full Text] [Related]
[Next]
